Logo

Enhancing Cell Line Development: Viability & IgG Detection with Cyto-Cellect

Data

martedì, 29 aprile 2025

Orario

15:00 Europe/London

Converti nel mio fuso orario
Campo obbligatorio.
Campo obbligatorio.
Campo obbligatorio.
Campo obbligatorio.
Campo obbligatorio.
Campo obbligatorio.
Campi obbligatori
Se sei già registrato e non puoi localizzare la tua email di conferma registrazione, clicca qui!
Indirizzo email é invalido o non é stato fornito durante il processo di registrazione. Fornisci l'indirizzo email valido.

A confirmation email with logging details has been sent to the provided email.

Test di configurazione del sistema. Clicca qui!

Please note we may be in contact with you after the event with an updated recording of the webinar in the event of technical difficulties, or answers to questions that were missed in this live event.

Webinar Title:
Enhancing Cell Line Development: Viability & IgG Detection with Cyto-Cellect®


Description:
Discover how to supercharge your cell line development and antibody discovery workflows! In this webinar, we’ll explore how the Cyto-Cellect® Human IgG Kappa and Viability Assay Kit helps you rapidly pinpoint high-producing cells while eliminating non-viable ones—ensuring you select only the best candidates. Our experts will guide you through the science, best practices, and real-world applications of this innovative assay. Whether you're optimizing cell line development or accelerating antibody discovery, this session will equip you with the tools to enhance efficiency and confidence in your results.


Key Takeaways:

  • Accelerate Selection – Identify and isolate the most productive antibody-secreting cells with high specificity.
  • Ensure Cell Viability – Exclude apoptotic and necrotic cells using Annexin V staining for improved accuracy.
  • Optimize Your Workflow – Seamlessly integrate IgG detection and viability assessment within a single assay.
  • Enhance Confidence in Your Results – Leverage FRET-based technology for robust, reproducible data.


Register now to discover how our innovative solution can accelerate your bioprocessing workflows!



Ben Duckless

Senior Field Application Scientist, Sphere Bio

Ben Duckless is a Senior Field Application Scientist at Sphere Bio, specializing in single-cell analysis and functional screening technologies. With a background in life sciences, he brings extensive expertise in supporting researchers to optimize workflows for antibody discovery, cell line development, and therapeutic screening.

Ben holds a degree from the University of New Hampshire’s College of Life Sciences and Agriculture. His career spans roles in scientific applications and technical support, where he has helped scientists leverage cutting-edge microfluidics and picodroplet-based platforms to accelerate their research.

At Sphere Bio, Ben plays a key role in demonstrating the capabilities of Cyto-Mine® Chroma, ensuring customers maximize the benefits of high-throughput, multiplexed single-cell screening. His recent thought leadership includes insights on how multiplexing enhances precision in cell selection, driving efficiency and innovation in biopharmaceutical development.